Alternatives to cytology in the management of non-muscle invasive bladder cancer (original) (raw)
Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
David Schilling
Advances in Urology, 2011
View PDFchevron_right
Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria
Jack Barkin, Godfrey K Jansz, Julia Bridge
The Journal of Urology, 2006
View PDFchevron_right
The relationship between microscopic hematuria and bladder cancer: are currently available diagnostic methods reliable?
Yakup Kordan
Türk Üroloji Dergisi/Turkish Journal of Urology, 2010
View PDFchevron_right
Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?
Vladimir Yutkin
Expert Review of Anticancer Therapy, 2010
View PDFchevron_right
Cytology and Urinary Markers for the Diagnosis of Bladder Cancer
Theodorus Van Der Kwast
European Urology Supplements, 2009
View PDFchevron_right
A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study
Uri Lindner
European Urology Focus, 2016
View PDFchevron_right
Routine Urine Cytology has No Role in Hematuria Investigations
Bhaskar Somani, Omar Aboumarzouk
The Journal of Urology, 2013
View PDFchevron_right
Urine cytology, tumour markers and bladder cancer
Sarel Halachmi
BJU International, 1998
View PDFchevron_right
Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder Cancer
Arnulf Stenzl
Journal of Urology, 2000
View PDFchevron_right
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
Jörg Hennenlotter
Urologic Oncology: Seminars and Original Investigations, 2014
View PDFchevron_right
Sensitivity and specificity of 47kDa polyclonal antibody for detection of bladder cancer cells in urine of hematuria patients
Sumarno Prawiro
Biomarkers and Genomic Medicine, 2016
View PDFchevron_right
Immunocyt and the HA-HAase Urine Tests for the Detection of Bladder Cancer: A Side-by-Side Comparison
Marieta Toma
European Urology, 2004
View PDFchevron_right
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
Theodorus Van Der Kwast
European Urology, 2005
View PDFchevron_right
Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer
Wassim Kassouf, Molly Ingersoll, Bernd Schmitz-dräger, Peter Goebell, Rossana Critelli, Beate Pesch, Ashish Chandra
Urologic Oncology: Seminars and Original Investigations, 2014
View PDFchevron_right
Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
Oliver Hakenberg
European Urology, 2011
View PDFchevron_right
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis
Ruth Katz
Cancer cytopathology, 2010
View PDFchevron_right
Comparative Diagnostic Value of Urine Cytology, UBC-ELISA, and Fluorescence In Situ Hybridization for Detection of Transitional Cell Carcinoma of Urinary Bladder in Routine Clinical Practice
M. May
Urology, 2007
View PDFchevron_right
Comparative analysis of sensitivity to blood in the urine for urine-based point-of-care assays (UBC rapid, NMP22 BladderChek and BTA-stat) in primary diagnosis of bladder carcinoma. Interference of blood on the results of urine-based POC tests
Thomas Bschleipfer
Anticancer research, 2012
View PDFchevron_right
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma
Amos Shapiro, Benjamin Nisman
Cancer, 2002
View PDFchevron_right
Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer
Jörg Hennenlotter
Urology, 2012
View PDFchevron_right
Performance of Urine Test in Patients Monitored for Recurrence of Bladder Cancer: A Multicenter Study in the United States
Brian Stork
The Journal of Urology, 2005
View PDFchevron_right
Urine Cytology
Felix Brown
Urologic Clinics of North America, 2000
View PDFchevron_right
Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology
Badrinath Konety
European Urology, 2013
View PDFchevron_right
A SIDE BY SIDE COMPARISON OF CYTOLOGY AND BIOMARKERS FOR BLADDER CANCER DETECTION
sinan ekici
The Journal of …, 2004
View PDFchevron_right
Anticipatory Positive Urine Tests for Bladder Cancer
Richmond Owusu
Annals of surgical oncology, 2017
View PDFchevron_right
Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder
Marta Sanchez-carbayo
Urology, 1999
View PDFchevron_right
The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
Richmond Owusu
BMC Urology, 2016
View PDFchevron_right
“Atypical Cell’’ Parameter in Automated Urine Analysis for the Diagnosis of Bladder Cancer: A Retrospective Pilot Study
Bahadır Şahin
The Bulletin of Urooncology
View PDFchevron_right